Abstract

(Aust N Z J Obstet Gynaecol. 2016;56(2):127–136) In situations where the administration of blood or blood products is not a therapeutic option, management of obstetric hemorrhage can be extremely difficult and require additional multidisciplinary communication as well as unique approaches. Transfusion may not be an option when a woman has complex red cell antibodies or a rare blood group, because blood products are unavailable, or because the patient refuses transfusion for religious (as in the case of Jehovah’s Witnesses) or other reasons. In these circumstances, it is critically important that these women receive optimal management despite the inability to transfuse blood products. Research has shown that postpartum hemorrhage is the leading cause of maternal mortality and morbidity globally. A coordinated multidisciplinary approach, which may include blood products, is required in management of these situations.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.